Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2023-10-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
第六届董事会第二次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the company's sixth board of directors' second (extraordinary) meeting. It includes information about board meeting procedures, voting results, and approvals of various company matters such as management agreements, stock incentive plan adjustments, guarantees for subsidiaries, and approval of the company's 2023 third quarter report. The document is not the report itself but a formal announcement of board decisions and meeting outcomes. It does not contain full financial statements or detailed financial analysis but references other announcements and reports. Therefore, it fits best into the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2023-10-26 Chinese
独立董事关于第六届董事会第二次（临时）会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding the pre-approval of certain related-party transactions to be submitted to the company's board meeting. It references compliance with company law, securities law, and stock exchange regulations, and it is dated October 25, 2023. The content focuses on governance and approval of management agreements, not on financial results, audit, or shareholder voting outcomes. The document length is about 1000 characters, which is short and does not contain financial statements or detailed financial data. It is not an announcement of a report publication but a governance-related opinion. Therefore, the document fits best under Board/Management Information (MANG), as it relates to board meeting matters and independent directors' opinions on governance issues.
2023-10-26 Chinese
关于向激励对象首次授予限制性股票的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the initial grant of restricted shares (限制性股票) to incentive recipients under a 2023 stock incentive plan by 盈康生命科技股份有限公司. It details the grant date, number of shares, recipients, pricing, approval procedures, legal and financial advisor opinions, and compliance with regulatory requirements. The content focuses on the company's equity incentive plan implementation and related disclosures. This is not a full financial report, audit report, or earnings release, nor is it a general regulatory filing or a report publication announcement. It is a specific announcement about a capital change related to share issuance to employees and management as part of a stock incentive plan. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length (7539 characters) and detailed content support this classification with high confidence.
2023-10-26 Chinese
关于公司签署《委托管理协议》暨关联交易的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the signing of entrusted management agreements between the company and related parties, which are identified as related parties due to common control by the same ultimate controller. It discusses the nature of the agreements, the parties involved, the management scope, fees, and the approval process including board and supervisory committee approvals and independent directors' opinions. The document focuses on a specific transaction classified as a related party transaction and includes detailed disclosures required for such transactions. There is no indication that this is a full annual or interim financial report, earnings release, or other financial statement. It is not a proxy solicitation or voting results announcement. The document is a regulatory announcement about a related party transaction and the signing of management agreements, which fits best under Regulatory Filings (RNS) as it does not fit other more specific categories like Capital/Financing Update or M&A Activity. The document length and detail confirm it is not a brief announcement or a report publication announcement.
2023-10-26 Chinese
独立董事关于第六届董事会第二次（临时）会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's sixth board of directors' second (extraordinary) meeting. It includes opinions on related party transactions, adjustments to a 2023 restricted stock incentive plan, and the initial grant of restricted stock. The document references compliance with company law, stock exchange rules, and company articles, and it is a formal opinion rather than a financial report or announcement. It does not contain financial statements or earnings data, nor is it a regulatory filing or announcement of voting results. It is a governance-related document expressing independent directors' opinions on board matters, which fits best under Board/Management Information (MANG). The document length is short (2231 characters), and it is not a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2023-10-26 Chinese
关于召开2023年第四次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about convening the 2023 fourth extraordinary general meeting of shareholders for 盈康生命科技股份有限公司. It includes information about the meeting date, time, location, agenda items, voting procedures, registration details, and proxy forms. There is no financial data or report content, but rather an announcement and instructions related to a shareholders meeting. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is 4101 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the correct classification is AGM Information (AGM-R).
2023-10-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.